Form 4: Elevance Health CEO Buys Shares
Insider Transaction (Form 4)
Gail Boudreaux, President and CEO and a Director of Elevance Health, Inc., purchased 2,725 shares of common stock on July 17, 2026.
Summary
- Open-market purchase: acquired 680 Common Stock at $366.41 ($249,159) on July 17, 2026; holds 169,931 after (Direct).
- Open-market purchase: acquired 2,045 Common Stock at $368.25 ($753,071) on July 17, 2026; holds 171,976 after (Direct).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $1,002,230, committing personal capital to the stock.
Insider Transactions
Gail Boudreaux — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-17 | Open-market purchase | Common Stock | 680 | $366 | $249.2K | 169,931 |
| 2026-07-17 | Open-market purchase | Common Stock | 2,045 | $368 | $753.1K | 171,976 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-17 | Open-market purchase (680 shares) |
| 2026-07-17 | Open-market purchase (2,045 shares) |
Keywords
insider transaction, Form 4, ELV, Elevance Health, Inc., bullish, Gail Boudreaux
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.